These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34043455)

  • 1. Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic Landscape.
    Short NJ; Tallman MS; Pollyea DA; Ravandi F; Kantarjian H
    J Clin Oncol; 2021 Aug; 39(23):2535-2538. PubMed ID: 34043455
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.
    Harada Y; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kobayashi S; Kitamura K; Sakaida E; Onizuka M; Takeshita A; Ishida F; Suzushima H; Ishizawa K; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H;
    Leuk Res; 2018 Mar; 66():20-27. PubMed ID: 29360622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strategies to improve therapeutic efficacy in childhood acute myeloid leukemia].
    Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):108-10. PubMed ID: 24568899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.
    Faulk K; Gore L; Cooper T
    Paediatr Drugs; 2014 Jun; 16(3):213-27. PubMed ID: 24639021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia in the elderly.
    Ho C; Butera JN
    Med Health R I; 2011 Jan; 94(1):7-9. PubMed ID: 21290987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute myeloid leukemia: from risk-adapted to genotype-specific therapy].
    Kayser S; Schlenk RF
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1577-80. PubMed ID: 21809245
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in targeted therapy for childhood acute myeloid leukemia].
    Wang NN; Ye QD
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):832-836. PubMed ID: 28697841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New agents in acute myeloid leukemia and other myeloid disorders.
    Ravandi F; Kantarjian H; Giles F; Cortes J
    Cancer; 2004 Feb; 100(3):441-54. PubMed ID: 14745859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD19 and specific KIT-D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities.
    Wang B; Yang B; Ling Y; Zhang J; Hua X; Gu W; Yan F
    Cancer Med; 2021 Feb; 10(3):1091-1102. PubMed ID: 33382538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.
    Elgarten CW; Aplenc R
    Curr Opin Pediatr; 2020 Feb; 32(1):57-66. PubMed ID: 31815781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3 Inhibitors in the Management of Acute Myeloid Leukemia.
    Zappone E; Defina M; Aprile L; Bartalucci G; Gozzetti A; Bocchia M
    Anticancer Agents Med Chem; 2017; 17(8):1028-1032. PubMed ID: 27748173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?
    Tang K; Schuh AC; Yee KW
    Curr Oncol Rep; 2021 Aug; 23(10):120. PubMed ID: 34350512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
    Peterlin P; Gaschet J; Guillaume T; Garnier A; Eveillard M; Le Bourgeois A; Cherel M; Debord C; Le Bris Y; Theisen O; Godon C; Mahé B; Dubruille V; Wuilleme S; Touzeau C; Gastinne T; Blin N; Lok A; Tessoulin B; Le Gouill S; Moreau P; Béné MC; Chevallier P
    Cancer Med; 2021 Jan; 10(2):642-648. PubMed ID: 33369136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
    Boddu PC; Kadia TM; Garcia-Manero G; Cortes J; Alfayez M; Borthakur G; Konopleva M; Jabbour EJ; Daver NG; DiNardo CD; Naqvi K; Yilmaz M; Short NJ; Pierce S; Kantarjian HM; Ravandi F
    Cancer; 2019 Apr; 125(7):1091-1100. PubMed ID: 30521114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and risk stratification in patients with acute myeloid leukemia].
    Zhao XS; Chang YJ
    Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):259-263. PubMed ID: 33663179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk-adapted therapy of acute myeloid leukemia].
    Hiddemann W; Spiekermann K; Braess J; Feuring-Buske M; Buske C; Büchner T
    Internist (Berl); 2006 Jun; 47 Suppl 1():S33-9. PubMed ID: 16773364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia stem cell gene expression signatures contribute to acute myeloid leukemia risk stratification.
    Knorr KLB; Goldberg AD
    Haematologica; 2020 Mar; 105(3):533-536. PubMed ID: 32115413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.